Page last updated: 2024-09-04

levofloxacin and lactoferrin

levofloxacin has been researched along with lactoferrin in 3 studies

Compound Research Comparison

Studies (levofloxacin)	Trials (levofloxacin)	Recent Studies (post-2010) (levofloxacin)	Studies (lactoferrin)	Trials (lactoferrin)	Recent Studies (post-2010) (lactoferrin)
4,346	581	2,209	6,692	280	2,310

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cannaviello, C; De Francesco, V; Efrati, C; Hassan, C; Ierardi, E; Maconi, G; Manes, G; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A	1
Cellini, L; Ciccaglione, AF; Di Campli, E; Di Giulio, M; Di Lodovico, S; Marzio, L	1
Dȩbowski, D; Gitlin-Domagalska, A; Gucwa, K; Milewski, S; Okońska, J; Olkiewicz, K; Ptaszyńska, N; Rolka, K; Ruczyński, J; Łȩgowska, A	1

Trials

1 trial(s) available for levofloxacin and lactoferrin

Article	Year
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Middle Aged; Ofloxacin; Rabeprazole; Tinidazole; Treatment Outcome	2007

Article

Year

Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:9

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Middle Aged; Ofloxacin; Rabeprazole; Tinidazole; Treatment Outcome

2007

Other Studies

2 other study(ies) available for levofloxacin and lactoferrin

Article	Year
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4 Topics: Adult; Aged; Animals; Anti-Bacterial Agents; Cattle; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Young Adult	2019
Antibiotic-Based Conjugates Containing Antimicrobial HLopt2 Peptide: Design, Synthesis, Antimicrobial and Cytotoxic Activities. ACS chemical biology, 2019, 10-18, Volume: 14, Issue:10 Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Ciprofloxacin; Drug Stability; Escherichia coli; Fluconazole; HEK293 Cells; Hep G2 Cells; Humans; Immunoconjugates; Lactoferrin; Levofloxacin; Male; Microbial Sensitivity Tests; Peptide Fragments; Staphylococcus aureus; Swine	2019

Article

Year

Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study.

The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4

Topics: Adult; Aged; Animals; Anti-Bacterial Agents; Cattle; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Young Adult

2019

Antibiotic-Based Conjugates Containing Antimicrobial HLopt2 Peptide: Design, Synthesis, Antimicrobial and Cytotoxic Activities.

ACS chemical biology, 2019, 10-18, Volume: 14, Issue:10

Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Ciprofloxacin; Drug Stability; Escherichia coli; Fluconazole; HEK293 Cells; Hep G2 Cells; Humans; Immunoconjugates; Lactoferrin; Levofloxacin; Male; Microbial Sensitivity Tests; Peptide Fragments; Staphylococcus aureus; Swine

2019